As diabetes care continues to be a crucial focus, new treatments are emerging . Retatrutide, Tirzepatide, and Semaglutide represent a exciting generation in incretin mimetic medications. While all aim to https://followbookmarks.com/story22279290/retatrutid-vs-tirzepatid-vs-semaglutide-a-head-to-head-analysis